Different expression and distribution of 11β-hydroxysteroid dehydrogenase type 1 in obese and lean animal models of type 2 diabetes (Short communication)

I. Czegle, É Margittai, S. Senesi, A. Benedetti, G. Bánhegyi

Research output: Contribution to journalArticle

2 Citations (Scopus)


11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) is a NADPH dependent oxidoreductase of the endoplasmic reticulum lumen which converts cortisone to cortisol and plays a role in the pathogenesis of metabolic syndrome and type 2 diabetes. The aim of our study was to investigate the correlation between the expression/activity of 11βHSD1 and obesity. Liver and adipose tissue microsomes of an obese (Zucker) and a non-obese (Goto-Kakizaki) type 2 diabetes model rat strains were used. 11βHSD1 expression was detected at mRNA, protein and activity level. The activity of 11βHSD1 was increased in the adipose tissue and decreased in the liver of the obese Zucker rat, while its mRNA levels were significantly different only in the adipose tissue. In diabetic Goto-Kakizaki rat both the expression and the activity of 11βHSD1 were elevated in liver, but not in adipose tissue. These results suggest that the prereceptorial glucocorticoid activation is different in the liver and adipose tissue of the two diabetes models. This phenomenon might be responsible for the obese and lean phenotypes in type 2 diabetes.

Original languageEnglish
Pages (from-to)419-424
Number of pages6
JournalActa physiologica Hungarica
Issue number4
Publication statusPublished - Dec 1 2008



  • 11β-hydroxysteroid dehydrogenase type 1
  • Endoplasmic reticulum
  • Goto-Kakizaki rat
  • Obesity
  • Type 2 diabetes mellitus
  • Zucker rat

ASJC Scopus subject areas

  • Physiology (medical)

Cite this